NovaBridge Biosciences Cash Flow Statement (2019-2025) | NBP

Cash Flow Statement Sep2019 Dec2019 Sep2020 Dec2020 Dec2021 Jun2022 Dec2022 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter) -35.10M-49.46M166.65M160.85M25.04M-6.90M420.002.28M-33.62M-3.15M-5.50M6.83M-103.82M
Depreciation and Depletion (Quarter) 0.43M0.38M0.76M0.02M0.02M0.02M0.01M
Share-based Compensation (Quarter) -52.05M23.52M20.16M12.64M0.32M0.82M1.90M25.30M3.94M
Deferred Taxes (Quarter) -0.02M-0.02M
Cash from Discontinued Operations (Quarter) -33.64M26.46M
Gains from Equity Investments (Quarter) -0.03M
Gains from Investment Securities (Quarter) 5.46M-0.00M-0.85M-1.98M
Cash from Operations (Quarter) -30.64M153.34M8.42M-10.95M1.84M-14.60M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.18M0.19M0.20M0.20M
Amortization of Deferred Charges (Quarter) 0.41M
Depreciation & Amortization (CF) (Quarter) 0.43M0.38M0.76M0.02M0.02M0.02M0.01M
Change in Working Capital
Change in Accured Expenses (Quarter) 22.16M0.28M28.87M-0.24M-3.31M8.64M10.71M
Other Working Capital Changes (Quarter) -0.14M-0.14M-0.21M1.12M
Investing Activities
Capital Expenditures (Quarter) 2.39M-0.67M1.93M-0.00M-0.04M
Change in Acquisitions & Divestments (Quarter) 31.31M19.27M336.02M-57.79M-81.43M
Cash from Investing Activities (Quarter) 10.97M-41.43M8.22M-81.66M-0.11M
Financing Activities
Other financing activities (Quarter) 420.83M-0.97M1.17M
Debt Issuance and Repayment
Long-Term Debt Repayments (Quarter) 22.70M15.09M
Change in Capital Stock
Shares Issued (Quarter) 1.92M1.60M1.18M0.72M0.61M2.00M9.98M25.68M28.36M
Misc.
Cash from Financing Activities (Quarter) 16.07M280.56M127.47M60.75M-3.02M
Exchange Rate Effect (Quarter) -8.86M-3.23M-17.61M0.60M-0.01M0.07M0.19M
Change in Cash (Quarter) -12.45M202.27M271.42M-72.63M-11.06M62.66M-17.43M
Free Cash Flow (Quarter) -33.04M0.67M151.41M8.42M-10.91M1.84M-14.60M
Net Cash Flow (Quarter) -3.60M239.14M289.03M-73.23M-11.06M62.59M-17.62M